Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows
(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.